125 related articles for article (PubMed ID: 6648143)
41. The effect of mass screening for breast cancer: results of a multivariate analysis.
Kuroishi T; Tominaga S; Ota J; Horino T; Taguchi T; Ishida T; Yokoe T; Izuo M; Ogita M; Itoh S
Jpn J Cancer Res; 1991 Jan; 82(1):27-32. PubMed ID: 1900263
[TBL] [Abstract][Full Text] [Related]
42. Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival.
Xu JL; Fagerstrom RM; Prorok PC
Stat Med; 1999 Jan; 18(2):155-62. PubMed ID: 10028136
[TBL] [Abstract][Full Text] [Related]
43. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom.
Miltenburg GA; Peeters PH; Fracheboud J; Collette HJ
Br J Cancer; 1998 Oct; 78(7):962-5. PubMed ID: 9764591
[TBL] [Abstract][Full Text] [Related]
44. Bias in breast cancer research in the screening era.
Cox B; Sneyd MJ
Breast; 2013 Dec; 22(6):1041-5. PubMed ID: 23988397
[TBL] [Abstract][Full Text] [Related]
45. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
De Koning HJ; Fracheboud J; Boer R; Verbeek AL; Collette HJ; Hendriks JH; van Ineveld BM; de Bruyn AE; van der Maas PJ
Int J Cancer; 1995 Mar; 60(6):777-80. PubMed ID: 7896444
[TBL] [Abstract][Full Text] [Related]
46. A model-based analysis of the HIP project for breast cancer screening.
van Oortmarssen GJ; Habbema JD; Lubbe JT; van der Maas PJ
Int J Cancer; 1990 Aug; 46(2):207-13. PubMed ID: 2384271
[TBL] [Abstract][Full Text] [Related]
47. Evaluating cancer screening programs using survival analysis.
Vratanar B; Pohar Perme M
Biom J; 2023 Oct; 65(7):e2200344. PubMed ID: 37278228
[TBL] [Abstract][Full Text] [Related]
48. Secondary prevention: screening for breast cancer.
Chamberlain J
Eff Health Care; 1985; 2(5):179-88. PubMed ID: 10271344
[TBL] [Abstract][Full Text] [Related]
49. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
50. Mammography screening. Benefits, harms, and informed choice.
Jørgensen KJ
Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
[TBL] [Abstract][Full Text] [Related]
51. Interval carcinomas of the breast: a group with intermediate outcome.
Schroën AA; Wobbes T; van der Sluis RF
J Surg Oncol; 1996 Nov; 63(3):141-4. PubMed ID: 8944056
[TBL] [Abstract][Full Text] [Related]
52. Estimating benefits of screening from observational cohort studies.
Flanders WD; Longini IM
Stat Med; 1990 Aug; 9(8):969-80. PubMed ID: 2218198
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer screening.
Jatoi I
Am J Surg; 1999 Jun; 177(6):518-24. PubMed ID: 10414706
[TBL] [Abstract][Full Text] [Related]
54. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
55. All-cause mortality in randomized trials of cancer screening.
Black WC; Haggstrom DA; Welch HG
J Natl Cancer Inst; 2002 Feb; 94(3):167-73. PubMed ID: 11830606
[TBL] [Abstract][Full Text] [Related]
56. Screening for breast cancer detects tumours at an earlier biological stage.
Crisp WJ; Higgs MJ; Cowan WK; Cunliffe WJ; Liston J; Lunt LG; Peakman DJ; Young JR
Br J Surg; 1993 Jul; 80(7):863-5. PubMed ID: 8369918
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
58. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
59. Twenty-year review of a breast cancer screening project. Ninety-five percent survival of patients with nonpalpable cancers.
Letton AH; Mason EM; Ramshaw BJ
Cancer; 1996 Jan; 77(1):104-6. PubMed ID: 8630914
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
